Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 46

Results For "EY"

5016 News Found

Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push
Biotech | June 10, 2026

Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push

The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities


Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore
News | June 10, 2026

Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore

The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe


NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan
Opinion | June 10, 2026

NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan

The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India


Hoola Health raises $5 million to expand child-centric paediatric care
Startup | June 10, 2026

Hoola Health raises $5 million to expand child-centric paediatric care

Bengaluru-based startup will use the fresh capital to enter new markets, enhance technology capabilities, and scale its integrated care model


HAB Pharma targets Rs. 3,000 crore revenue by 2030
News | June 10, 2026

HAB Pharma targets Rs. 3,000 crore revenue by 2030

Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions


Ajanta Pharma elevates Atul Galgalikar as Vice President for international business
People | June 10, 2026

Ajanta Pharma elevates Atul Galgalikar as Vice President for international business

Pharma industry veteran brings more than two decades of experience in sales, marketing, business development, and global market expansion to his new leadership role


Cipla elevates Manoj Dimri as Group Business Head
People | June 10, 2026

Cipla elevates Manoj Dimri as Group Business Head

Pharma industry veteran brings extensive experience in commercial strategy, business growth, and market leadership to his expanded role at Cipla


Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce
Policy | June 10, 2026

Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce

Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports


FDA greenlights Lilly’s EBGLYSS for ultra-low-frequency dosing in eczema breakthrough
R&D | June 10, 2026

FDA greenlights Lilly’s EBGLYSS for ultra-low-frequency dosing in eczema breakthrough

The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year


DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability excellence
Sustainability | June 10, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability excellence

Recognition places pharmaceutical excipients leader among the top 5% of companies globally, highlighting progress in emissions reduction, responsible sourcing, and sustainable supply chain practices